Comparison Between Outcomes of Pregnant Women Treated With Ferinject vs. Venofer for Iron Deficiency Anemia

Phase 4RecruitingNCT06061393

Western Galilee Hospital-Nahariya200 enrolled

Overview

The purpose of this study is to compare maternal outcomes such as increased hemoglobin need for blood transfusion and hemoglobin level before and post partum in women with hemoglobin \<9 gr/dl , treated with venofer and women treated with ferinject.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

200

Conditions

Anemia, Iron Deficiency Pregnancy Anemia

Interventions

Venofer 200 MG Per 10 ML InjectionDRUG

treat anemia with venofer up to 5 doses

FerinjectDRUG

ferinject 500 mg, once a week for 2 weeks

Eligibility

Sex: FEMALEMin age: 18 YearsMax age: 50 Years

Medical Language ↔ Plain English

Inclusion Criteria: pregnancy\>24 weeks of gestation anemia with Hb\<9 anemia with Hb\<9.5 if symptomatic anemia or previous postpartum hemorrhage Exclusion Criteria: * Allergy to one of the study's drugs * IV iron treatment in the last month * Underlying medical conditions associated with anemia, such as thalassemia Major, renal insufficiency, or spherocytosis * Twin pregnancy * non iron deficiency anemia

Locations (1)

Galilee Medical Center

Nahariya, Israel

RECRUITING

Outcomes

Primary Outcomes

ratio of women with Hb level >11 at delivery

Hb level

Time frame: at delivery

postpartum Hb level

gr/dl

Time frame: during 48 hours after delivery

Central Contacts

maya Wolf, MD

CONTACT

972507887800 mayaw@gmc.gov.il

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.